Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMBEV S.A. Regulatory Filings 2017

Dec 8, 2017

30093_ffr_2017-12-08_aefc64ba-557a-41ba-ab1f-9f6cb6f2ac1b.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 ambevsacvm358nov2017_6k1.htm AMBEVSACVM358NOV2017_6K1 ambevsacvm358nov2017_6k1.htm - Generated by SEC Publisher for SEC Filing

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of December, 2017

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor 04530-000 São Paulo, SP Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F X Form 40-F _

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes _ No X_

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives Securities Characteristics (2) Quantity %
Same Class and Type Total
Shares Common 9,655,277 0.0614 0.0614
Transac tions in the month
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price Volume (R$) (3)
Shares Common Direct with the Company Conversion in ADRs 03 120,850 0.00 0.00
Shares Common Direct with the Company Conversion in ADRs 17 261,000 0.00 0.00
Shares Common Direct with the Company Conversion in ADRs 29 78,890 0.00 0.00
Total Conversion ADRs (Out) 460,740 0.00
Shares Common Direct with the Company Exerc Options 13 42,325 3.12096 132,094.63
Shares Common Direct with the Company Exerc Options 13 45,175 9.35960 422,819.93
Shares Common Direct with the Company Exerc Options 13 25,385 11.97200 303,909.22
Shares Common Direct with the Company Exerc Options 20 25,385 11.97200 303,909.22
Shares Common Direct with the Company Exerc Options 22 59,750 1.29648 77,464.68
Shares Common Direct with the Company Exerc Options 22 46,000 3.12096 143,564.16
Shares Common Direct with the Company Exerc Options 23 43,900 1.09284 47,975.68
Shares Common Direct with the Company Exerc Options 30 30,125 9.35960 281,957.95
Shares Common Direct with the Company Exerc Options 30 63,465 11.97200 759,802.98
Shares Common Direct with the Company Exerc Options 30 77,665 17.19800 1,335,682.67
Total Sell 459,175 3,809,181.12
Shares Common Direct with the Company Plan of Shares Acquisition 13 42,474 20.22 858,824.28
Shares Common Direct with the Company Plan of Shares Acquisition 20 14,796 20.54 303,909.84
Shares Common Direct with the Company Plan of Shares Acquisition 21 30,000 20.81 624,300.00
Shares Common Direct with the Company Plan of Shares Acquisition 30 115,636 20.56 2,377,476.16
Total Buy 202,906 4,164,510.28
Final Balance
Securities / Derivatives Securities Characteristics (2) Quantity %
Same Class and Type Total
Shares Common 8,938,268 0.0569 0.0569

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.
Name: Ambev S.A. CPF/CNPJ: 07.526.557/0001-00
Qualification: Outstanding Shares in Treasury
Initial Balance
Securities / Derivatives Securities Characteristics (2) Quantity %
Same Class and Type Total
ADR (*) Common 0 0.0000 0.0000
Transac tions in the month
Securities / Derivatives Securities Characteristics (2) Intermediary Operation Day Quantity Price USD Volume (USD) (3)
ADR (*) Common Direct with the Company Conversion in ADRs 03 120,850 0.00 0.00
ADR (*) Common Direct with the Company Conversion in ADRs 17 261,000 0.00 0.00
ADR (*) Common Direct with the Company Conversion in ADRs 29 78,890 0.00 0.00
Total Conversion ADRs (In) 460,740 0.00
ADR (*) Common Direct with the Company Plan of Shares Acquisition 29 76,135 6.30 479,647.35
Total Buy 76,135 479,647.35
ADR (*) Common Direct with the Company Exerc Options 03 36,900 0.000000 0.00
ADR (*) Common Direct with the Company Exerc Options 03 44,475 1.130456 50,277.03
ADR (*) Common Direct with the Company Exerc Options 03 39,475 2.234470 88,205.70
ADR (*) Common Direct with the Company Exerc Options 17 59,250 1.248396 73,967.46
ADR (*) Common Direct with the Company Exerc Options 17 110,500 0.000000 0.00
ADR (*) Common Direct with the Company Exerc Options 17 53,350 1.130456 60,309.83
ADR (*) Common Direct with the Company Exerc Options 17 37,900 2.234470 84,686.41
ADR (*) Common Direct with the Company Exerc Options 29 155,025 3.094000 479,647.35
Total Sell 536,875 837,093.78
Final Balance
Securities / Derivatives Securities Characteristics (2) Quantity %
Same Class and Type Total
ADR (*) Common 0 0.0000 0.0000

(1) When filling in the form, delete the lines that do not have any information. If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information.

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(3) Quantity multiplied by price .

(*) Each ADR is equivalent to 1 (one) share.

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In November 2017:

( X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002. (1)

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Subsidiary Name: Ambev Luxembourg S.À.R.L.
Qualification: Position – Total Return Swap
Transac tions in the month
Securities / Derivatives Securities Characteristics (1) Intermediary Operation Day Quantity (**) Price USD Volume (USD) (2)
Swap Swap referenced in Shares N/A Total Return Swap Conclusion 06 (*) 1,215,000 20.5670 24,988,905.00
Swap Swap referenced in Shares N/A Total Return Swap Conclusion 08 (*) 221,000 20.0475 4,430,497.50
Swap Swap referenced in Shares N/A Total Return Swap Conclusion 10 (*) 291,500 20.0330 5,839,619.50
Total operation 1,727,500 35,259,022.00

(1) Issue/Series, convertibility, simple, term, guaranties, type/class, among others.

(2) Quantity multiplied by price .

(*) In accordance with the Circular Letter/CVM/SEP/Nº07/2017, date information of the total return swap conclusion and not the date of the financial settlement of the transaction.

() The reported quantity is not actually related to a purchase or sale, but an economic exposure arising from the conclusion of a swap agreement on a consolidated basis, in accordance with the Circular Letter/CVM/SEP/Nº07/2017.**

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: December 8, 2017

AMBEV S.A.
By: /s/ Ricardo Rittes de Oliveira Silva
Ricardo Rittes de Oliveira Silva Chief Financial and Investor Relations Officer